These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30573802)

  • 1. Communication about genetic testing with breast and ovarian cancer patients: a scoping review.
    Jacobs C; Patch C; Michie S
    Eur J Hum Genet; 2019 Apr; 27(4):511-524. PubMed ID: 30573802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling.
    Decruyenaere M; Evers-Kiebooms G; Denayer L; Welkenhuysen M; Claes E; Legius E; Demyttenaere K
    Eur J Hum Genet; 2000 Feb; 8(2):130-6. PubMed ID: 10757645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrafamilial communication of hereditary breast and ovarian cancer genetic information in Italian women: towards a personalised approach.
    Di Pietro ML; Zaçe D; Orfino A; Di Raimo FR; Poscia A; de Matteis E; Turchetti D; Godino L; Bertonazzi B; Franiuk M; Bruzzone C; Varesco L; Lucci-Cordisco E; Genuardi M
    Eur J Hum Genet; 2021 Feb; 29(2):250-261. PubMed ID: 32929237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer.
    Hopwood P
    Curr Opin Oncol; 2005 Jul; 17(4):340-4. PubMed ID: 15933464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
    Nippert I; Schlegelberger B;
    Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer.
    Contegiacomo A; Pensabene M; Capuano I; Tauchmanova L; Federico M; Turchetti D; Cortesi L; Marchetti P; Ricevuto E; Cianci G; Venuta S; Barbieri V; Silingardi V;
    Ann Oncol; 2004 May; 15(5):726-32. PubMed ID: 15111339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
    Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
    J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
    Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
    Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review.
    Afaya A; Kim SW; Park HS; Lim MC; Jung MS; Nam EJ; Park JS; Jeong J; Ryu JM; Kim J; Kim J; Kim M; Jin J; Han J; Kim SY; Park SY; Katapodi MC; Kim S;
    Fam Cancer; 2024 Jun; 23(2):121-132. PubMed ID: 38662264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
    Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
    Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's need for information before attending genetic counselling for familial breast or ovarian cancer: a questionnaire, interview, and observational study.
    Hallowell N; Murton F; Statham H; Green JM; Richards MP
    BMJ; 1997 Jan; 314(7076):281-3. PubMed ID: 9022494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement.
    Ricci MT; Sciallero S; Mammoliti S; Gismondi V; Franiuk M; Bruzzi P; Varesco L
    Public Health Genomics; 2015; 18(4):225-32. PubMed ID: 26111740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer.
    Cicero G; De Luca R; Dorangricchia P; Lo Coco G; Guarnaccia C; Fanale D; Calò V; Russo A
    J Genet Couns; 2017 Oct; 26(5):999-1007. PubMed ID: 28283917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.